Biopharmaceutical Industry | Impact Entrepreneur

The Case for a USA Public Benefit Biotechnology Industry

The Case for a USA Public Benefit Biotechnology Industry

by Barbara Handelin | Blended Finance & Philanthropy, Editor's Picks, Global, Impact Economy, Impact Investing, North America, SDG 3 - Good Health and Well-Being, Stakeholder Capitalism, Systems Change